AFA
Alta Fundamental Advisers’s Milestone Pharmaceuticals MIST Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.71M | Sell |
1,398,977
-28,502
| -2% | -$55.3K | 1.39% | 18 |
|
|
2025
Q1 | $1.14M | Sell |
1,427,479
-1,231,110
| -46% | -$985K | 0.73% | 18 |
|
|
2024
Q4 | $6.27M | Hold |
2,658,589
| – | – | 1.88% | 12 |
|
|
2024
Q3 | $4.04M | Hold |
2,658,589
| – | – | 1.16% | 12 |
|
|
2024
Q2 | $3.51M | Buy |
2,658,589
+287,300
| +12% | +$379K | 1.11% | 13 |
|
|
2024
Q1 | $4.24M | Buy |
2,371,289
+700,000
| +42% | +$1.25M | 1.61% | 9 |
|
|
2023
Q4 | $2.79M | Buy |
1,671,289
+495,100
| +42% | +$827K | 1.26% | 9 |
|
|
2023
Q3 | $3.65M | Buy |
1,176,189
+278,228
| +31% | +$863K | 1.74% | 6 |
|
|
2023
Q2 | $2.56M | Hold |
897,961
| – | – | 1.25% | 9 |
|
|
2023
Q1 | $3.54M | Buy |
897,961
+332,500
| +59% | +$1.31M | 1.5% | 12 |
|
|
2022
Q4 | $2.24M | Buy |
+565,461
| New | +$2.24M | 0.97% | 14 |
|